Dunhill Financial’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Dunhill Financial's HALO Position: Q3 2026 in Review
Dunhill Financial increased its Halozyme (HALO) stake by 2,100% in Q3 2026, buying an estimated $10.1K and bringing the position to 110 shares worth $660. The position accounts for ﹤0.01% of the portfolio, ranked #1145.
Dunhill Financial first reported a position in HALO in Q4 2025 and has held it in 4 quarters since. 774 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Dunhill Financial held 110 shares of Halozyme worth $660 as of Q3 2026.
- Dunhill Financial bought 105 Halozyme shares in Q3 2026, an estimated $10.1K.
- Halozyme made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #1145 holding.
- Dunhill Financial first reported a position in Halozyme in Q4 2025 and has held it in 4 quarters since.
- 774 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.